Wells Fargo
CELL

Wells Fargo’s PhenomeX Inc. Common Stock CELL Stock Holding History

Wells Fargo’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,196
Closed -$1.19K – 7840
2023
Q3 		$1.19K Buy
1,196
+677
+130% +$519 ﹤0.01% 6173
2023
Q2 		$254 Sell
519
-9,801
-95% -$8.02K ﹤0.01% 6631
2023
Q1 		$12K Buy
10,320
+10,120
+5,060% +$18.5K ﹤0.01% 5801
2022
Q4 		$536 Sell
200
-21,700
-99% -$57.2K ﹤0.01% 6372
2022
Q3 		$63K Buy
21,900
+8,135
+59% +$34.6K ﹤0.01% 4843
2022
Q2 		$68K Sell
13,765
-15,956
-54% -$83.6K ﹤0.01% 4867
2022
Q1 		$211K Sell
29,721
-45,421
-60% -$376K ﹤0.01% 4951
2021
Q4 		$1.37M Buy
75,142
+23,039
+44% +$497K ﹤0.01% 3843
2021
Q3 		$1.02M Sell
52,103
-1,410,684
-96% -$53.6M ﹤0.01% 4223
2021
Q2 		$65.5M Buy
1,462,787
+313,466
+27% +$14.5M 0.01% 903
2021
Q1 		$57.7M Buy
1,149,321
+521,936
+83% +$35.6M 0.01% 965
2020
Q4 		$56.1M Buy
627,385
+103,643
+20% +$8.72M 0.01% 916
2020
Q3 		$40M Buy
+523,742
New +$33.3M 0.01% 1003

Wells Fargo's CELL Position: Q4 2023 in Review

Wells Fargo sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 1,196 shares — an estimated $1.19K sold.

Wells Fargo first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $65.5M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

  • Wells Fargo reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Wells Fargo sold 1,196 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $1.19K.
  • Wells Fargo first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Wells Fargo's PhenomeX Inc. Common Stock position peaked at $65.5M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.